Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of the bispecific antibody MCLA-158 in patients with advanced solid tumors. Recruitme…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies
Viome's completed clinical trial update reports analyses of the intestinal microbiome, oral microbiome, and whole-blood transcriptome across…
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer [Phase 2]
Phase 2 trial evaluating low-dose radiotherapy combined with chemotherapy and AK112 as second-line treatment for advanced gastric and gastro…
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating envafolimab in combination with fruquintinib and chemotherapy as neoadjuvant treatment for gastric cancer,…
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: ProSight: a Multi-centre Interventional Study Evaluating MCED in Asymptomatic Population [NA]
This clinical trial update describes the ProSight multi-centre interventional study evaluating a multi-cancer early detection (MCED) test in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: PD-1 Antibody Carilizumab Combined with Apatinib for Unresectable Stage III and IV DMMR Gastric Cancer [Phase 2]
A Phase 2 trial is evaluating the combination of Carilizumab, a PD-1 antibody, with Apatinib in unresectable stage III/IV mismatch repair-de…
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer [NA]
This clinical trial investigates the effectiveness of risk-based sequential screening for esophageal and gastric cancers and is currently re…
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting
A clinical trial led by Peking Union Medical College Hospital is currently recruiting to predict drug response in gastric cancer using 3D bi…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of CBX-12 in adults with advanced or metastatic refractory solid tumors. The trial includes multiple cancer types and is cur…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Retrospective Data Collection for a Correlation Study Between Gastric Cancer and Clinical and Laboratory Variables
This completed study involves retrospective data collection to examine correlations between gastric cancer and a range of clinical and labor…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: The Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric Cancer
A clinical trial exploring how psychological stress influences therapy efficacy and prognosis in gastric cancer and gastroesophageal junctio…
-
CLINICAL_TRIALS research · 2025-01-21Clinical Trial Update: Differences in Gastric Microbiota in Patients Who Were Infected Between CagA Positive and Negative Helicobacter Pylori [NA]
Mahidol University is conducting a clinical trial to compare gastric microbiota in patients infected with CagA-positive versus CagA-negative…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Use of Pyrvinium to Reverse Stomach Precancerous Conditions [Phase 2]
A Phase 2 clinical trial evaluating pyrvinium to reverse stomach precancerous conditions, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer [Phase 1, Phase 2]
Phase Ib/II trial evaluating adebrelimab in combination with capecitabine and oxaliplatin for gastric cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-15Clinical Trial Update: Screening of Small Non-coding RNAs as an Auxiliary Diagnostic Biomarker for Gastric Cancer
ClinicalTrials.gov update describing a study enrolling to evaluate small non-coding RNAs as an auxiliary diagnostic biomarker for gastric ca…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: A Study of Fruquintinib Plus Chemotherapy for Postoperative Treatment of HER2-Negative Gastric Cancer With Poor TRG [Phase 2]
Phase 2 trial evaluating Fruquintinib plus chemotherapy as postoperative treatment for HER2-negative gastric cancer with poor tumor regressi…
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers [Phase 2]
This Phase 2 trial aims to evaluate whether reducing the dosing frequency of immune checkpoint inhibitors is feasible across advanced cancer…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: A Multi-center Real-world Efficacy and Safety of Trastuzumab-deruxtecan in Advanced Gastric Cancer
A multi-center real-world study is evaluating the efficacy and safety of trastuzumab-deruxtecan in advanced gastric cancer and is currently …
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Zolbetuximab Claudin18.2 Positive, HER2 Negative, Advanced Gastric Cancer
A clinical trial update indicates that zolbetuximab is being tested in Claudin18.2-positive, HER2-negative advanced gastric cancer and is cu…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Tislelizumab Combined with SOX Regimen in the Treatment of Locally Advanced Gastric Cancer/gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating tislelizumab plus the SOX regimen (S-1 and oxaliplatin) for locally advanced gastric cancer or gastroesoph…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Pilot Study for High Output Drainage Removal After Gastrectomy [NA]
Pilot clinical trial evaluating high-output drainage removal after gastrectomy for gastric cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: TAS102 in Combination With NAL-IRI in Advanced GI Cancers [Phase 1, Phase 2]
This document provides an update on an ongoing Phase 1/2 clinical trial evaluating the combination of TAS-102 with nanoliposomal irinotecan …
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: A Prospective Cohort Study on the Treatment of Locally Advanced Gastric Cancer
A prospective cohort study investigating treatments for locally advanced gastric cancer; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer [NA]
This entry describes a clinical study evaluating taurine in combination with neoadjuvant chemo-immunotherapy for locally advanced gastric ca…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) [NA]
The LIVELONG trial from University of California, Davis is an ongoing study evaluating locally ablative therapy for oligoprogressive gastroi…